William B. Walkup & Associates’s Haemonetics HAE Stock Holding History

William B. Walkup & Associates’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.38K	Buy	+45	New	+$2.89K	﹤0.01%	171

Other funds holding HAE

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return

Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Retirement Systems of Alabama

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS)

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

William B. Walkup & Associates's HAE Position: Q2 2026 in Review

William B. Walkup & Associates opened a new position in Haemonetics (HAE) in Q2 2026: 45 shares worth $3.38K. The stake represents ﹤0.01% of the portfolio and ranks #171 among its holdings.

87 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

William B. Walkup & Associates held 45 shares of Haemonetics worth $3.38K as of Q2 2026.
Haemonetics was a new William B. Walkup & Associates position in Q2 2026.
Haemonetics made up ﹤0.01% of William B. Walkup & Associates's portfolio in Q2 2026, its #171 holding.
87 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on William B. Walkup & Associates's 13F filing for Q2 2026, filed 30 Jul 2026.